A randomized multi-center trial of elective revascularization with EPC [endothelial progenitor cell] capturing stenting versus drug eluting stenting in patients with de novo coronary lesions with a high risk of coronary restenosis: The Genous EPC capturing stent versus the paclitaxel or sirolimus eluting stent.

Trial Profile

A randomized multi-center trial of elective revascularization with EPC [endothelial progenitor cell] capturing stenting versus drug eluting stenting in patients with de novo coronary lesions with a high risk of coronary restenosis: The Genous EPC capturing stent versus the paclitaxel or sirolimus eluting stent.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Jan 2014

At a glance

  • Drugs Anti-CD34 monoclonal antibody (Primary) ; Everolimus; Paclitaxel; Sirolimus; Zotarolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms TRIAS-HR
  • Most Recent Events

    • 25 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top